← Back to Search

Education and Assistance for Normal Pressure Hydrocephalus (NPH Trial)

N/A
Waitlist Available
Led By Hossein Zare, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Must not have
People under 65 years old who have not completed the AWV survey
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months and 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine the prevalence of a condition called NPH in Baltimore and Maryland, focusing on how it affects different zip codes and racial groups, especially the Black community. The study will provide education

Who is the study for?
This trial is for individuals in Maryland, particularly from the Black community, who may be affected by Normal Pressure Hydrocephalus (NPH). It aims to address health disparities and improve care access. Participants should be interested in learning about NPH or are healthcare providers looking to enhance their understanding of NPH management.
What is being tested?
The study tests educational interventions on NPH for patients and primary care providers. It includes training programs designed to increase awareness and improve referral rates to specialists. The goal is also to measure how these trainings affect long-term healthcare utilization among different racial groups.
What are the potential side effects?
Since this trial focuses on education and training rather than medical treatments, there are no direct side effects associated with medications or procedures. However, participants may experience changes in their healthcare experiences as a result of increased knowledge.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 65 and haven't completed the AWV survey.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
number of screenings
Secondary study objectives
number of NPH's consultations
Other study objectives
number of referrals

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Patients and the patient's familyExperimental Treatment3 Interventions
All patients and the patient's family will receive NPH-related education.
Group II: PCPs TrainingExperimental Treatment2 Interventions
Primary Care Provider (PCP) will receive NPH education.
Group III: CHWs assist PCPsExperimental Treatment1 Intervention
A community health worker (CHW) will assist PCP.

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
426 Previous Clinical Trials
2,132,853 Total Patients Enrolled
Hossein Zare, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
~440 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top